(PharmaNewsWire.Com, January 26, 2018 ) The Global Interventional Neurology Device Market is expected to reach USD 3.66 billion by 2024, from USD 1.85 billion in 2016 growing at a CAGR of 8.9% during the forecast period of 2017 to 2024.
Neurology is that medical branch which deals with the whole brain and nervous(sensory system). Interventional neurology devices specializes in non-surgical activities that utililizes non invasive and picture guided procedures for the treatment of most dangerous diseases of neck, cerebrum, and spine commonly known as neurosurgery. It usually deals with the treatment of central nervous and peripheral system along with various diseases.
On the basis of product types, global interventional neurology devicemarket is segmented intoaneurysm coiling and embolization devices, angioplasty devices, micro support devices and neurothrombectomy devices. Aneurysm coiling and embolization devices are further sub segmented into embolic coils, flow diversion devices and liquid embolic devices. Angioplasty devices are divided into carotid artery stents and embolic protection systems. Micro support devices are further sub segmented into microguidewires and microcatheters. Neurothrombectomy devices are classified into CLOT retrieval devices, suction and aspiration devices, snares.
On the basis of end users, global interventional neurology device market is segmented into hospitals, neurology clinics, ambulatory care centers and others.
On the basis of geography, global interventional neurologydevice marketreport covers data points for 28 countries across multiple geographies namely North America, South America, Europe, Asia-Pacific and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, APAC is expected to dominate the market.
The global interventional neurology device market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of interventional neurology device market for global, Europe, North America, Asia Pacific and South America.
Major Market Competitors:
Some of the major players operating in the global interventional neurology device market are Medtronic, Stryker, TERUMO CORPORATION, Penumbra, Inc., Covidien, Abbott, Merit Medical Systems, Inc., Johnson & Johnson Services Inc., W. L. Gore & Associates, Inc., Bayer AG, MicroPort Scientific Corporation, Medikitco., Ltd., UreSil, LLC and, Boston Scientific Corporation, COOK,and Sequent Medical among other companies.
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
